At the Gavi COVAX AMC Summit on 2 June 2021, the UBS Optimus Foundation pledged a minimum of US$ 2.2 million to the Gavi COVAX AMC to help vulnerable communities in lower-income countries access COVID-19 vaccines during the pandemic. This was the first time that UBS had contributed to Gavi. The pledge came along with a dedicated revolving fundraising campaign reaching out to groups of philanthropists around the world.
UBS provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland. UBS is present in all major financial centres worldwide. It has offices in 52 countries and employs approximately 61,000 people around the world.
The UBS Optimus Foundation is a grant-making foundation that offers UBS clients a platform to use their wealth to drive positive social and environmental change. The foundation selects programmes that improve children’s health, education and protection – programmes that have the potential to be transformative, scalable and sustainable – as well as programmes tackling environmental and climate issues.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: